SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-308333
Filing Date
2020-12-02
Accepted
2020-12-02 15:33:28
Documents
2
Period of Report
2020-12-02
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d60911d8k.htm 8-K 16871
2 EX-3.1 d60911dex31.htm EX-3.1 4396
  Complete submission text file 0001193125-20-308333.txt   22545
Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Filer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39059 | Film No.: 201363619
SIC: 3841 Surgical & Medical Instruments & Apparatus